In cancer cells, FASN overexpression promotes their survival and proliferation via the activation of HER1/2 and EGFR receptors, which in turn induce FASN expression via the activation of the MAPK and PI3K/Akt/mTOR pathways [54]. Here, FASN is linked to cancer.